ondasdechoque.org
PT-BR

Shockwaves for myofascial pain: pooled evidence with reporting concerns · Review · 2022

Does shockwave ease myofascial pain more than other treatments?

In this review of 10 trials with 570 people, mostly with neck and upper-back muscle pain, pain just after treatment was about 1.3 points lower with shockwave than with other treatments, on average. Against dry needling, results were close.

Possible short-term help for myofascial pain
trials in the pain analysis
10
people, mostly with neck and upper-back pain
570
results pooled: pain, pressure tolerance, neck disability
3

Good to know: The trials varied widely in treatments and comparisons, and most followed people for a short time.

Wu T, Li S, Ren J, et al. Annals of Translational Medicine, 2022 · Read the paper ↗

How this study worked

10 studies570 peopleOne answer
A review gathers earlier studies to answer one question.

What happened

studies
10
people
570
Compared with
Trigger-point injections, dry needling, ultrasound, taping and other active treatments

Pain compared with other treatments

Pooled difference in pain score · end of treatment or a week later

Across 10 trials with 570 people, pain scores ended about 1.3 points lower with shockwave than with the comparison treatments, on average.
Show the numbers
Difference (pain score points)likely range
Pain, 10 trials−1.34−1.87 to −0.81

What the trials used

Protocol availability
ESWT protocols varied across the included studies; Table 1 names treatments but does not provide a reproducible device, energy, pulse and session schedule for each. The review cannot define one recommended dose.

Who took part

The authors report 571 people (541 with neck or upper-back pain, 30 with low back pain), but their tables add up to 570.

Side effects

The review did not count side effects across the trials; the authors, citing earlier research, describe shockwave as having no adverse effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

The authors report 571 participants, 541 with neck/upper-back pain and 30 with lumbar pain. However, Table 1 and the pain forest plot sum to 570 participants (283 experimental, 287 control). These conflicting source totals must remain visible; the pooled sample is not one new cohort.

Pain intensity1 reported outcome
01
End of treatment or one week later, as selected by review

Pain intensity

Pain intensity Source scale units; pooled MD

MD-1.34CI 95% -1.87 to -0.81p <0.00001

ESWT minus heterogeneous active comparators

10 studies · 570 participants in this estimate · I²=85%

-2.1Equal results 00.2

Reported pooled pain MD was −1.34 (95% CI −1.87 to −0.81; I²85%). Pressure threshold MD was +0.90 (0.73 to 1.07; I²98%) and NDI MD −1.79 (−2.48 to −1.10; I²92%). Figures 5 and 6 label the latter two models fixed-effect, contradicting the random-effects description. Individual comparisons with dry needling crossed the null; the review does not justify superiority to every comparator.

Analysis details and source

Model: random-effects. Source-reported estimate preserved without recalculation; participant count from forest plot, not conflicting abstract total.

Pressure pain threshold1 reported outcome
02
End of treatment or one week later, as selected by review

Pressure pain threshold

Pressure pain threshold Source scale units; pooled MD

MD0.9CI 95% 0.73 to 1.07p <0.00001

ESWT minus heterogeneous active comparators

6 studies · 364 participants in this estimate · I²=98%

-0.1Equal results 01.2

Reported pooled pain MD was −1.34 (95% CI −1.87 to −0.81; I²85%). Pressure threshold MD was +0.90 (0.73 to 1.07; I²98%) and NDI MD −1.79 (−2.48 to −1.10; I²92%). Figures 5 and 6 label the latter two models fixed-effect, contradicting the random-effects description. Individual comparisons with dry needling crossed the null; the review does not justify superiority to every comparator.

Analysis details and source

Model: fixed-effect in figure, random-effects in prose. Source-reported estimate preserved without recalculation; participant count from forest plot, not conflicting abstract total.

Neck disability1 reported outcome
03
End of treatment or one week later, as selected by review

Neck disability

Neck disability Source scale units; pooled MD

MD-1.79CI 95% -2.48 to -1.1p <0.00001

ESWT minus heterogeneous active comparators

3 studies · 264 participants in this estimate · I²=92%

-2.8Equal results 00.3

Reported pooled pain MD was −1.34 (95% CI −1.87 to −0.81; I²85%). Pressure threshold MD was +0.90 (0.73 to 1.07; I²98%) and NDI MD −1.79 (−2.48 to −1.10; I²92%). Figures 5 and 6 label the latter two models fixed-effect, contradicting the random-effects description. Individual comparisons with dry needling crossed the null; the review does not justify superiority to every comparator.

Analysis details and source

Model: fixed-effect in figure, random-effects in prose. Source-reported estimate preserved without recalculation; participant count from forest plot, not conflicting abstract total.

Dry-needling comparisons1 reported outcome
04
As reported in the source

Dry-needling comparisons

Dry-needling comparisons Narrative finding

Figure 4: Luan pain MD −0.18 (95% CI −0.66 to 0.30), Toghtamesh −0.25 (−0.93 to 0.43); both include no difference. Figure5 Luan pressure MD −0.04 (−0.29 to 0.21).

Analysis details and source

Qualitative finding; no invented effect estimate.

How treatment was delivered
Protocol availability

ESWT protocols varied across the included studies; Table 1 names treatments but does not provide a reproducible device, energy, pulse and session schedule for each. The review cannot define one recommended dose.

HARMS & TOLERABILITY

No systematic pooled adverse-event outcome or event denominator is supplied. The narrative claim of no adverse effects cannot establish safety. No funding or conflicts were declared.

LIMITS OF THE ANALYSIS

High heterogeneity, nonrandomized studies, English-only inclusion and many inaccessible/excluded full texts weaken causal and coverage claims. Model labels disagree with Methods for pressure threshold and NDI; study and participant totals disagree internally. A visually symmetric funnel with few studies cannot exclude reporting bias. The stated PEDro scoring framework also needs caution.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • High heterogeneity, nonrandomized studies, English-only inclusion and many inaccessible/excluded full texts weaken causal and coverage claims. Model labels disagree with Methods for pressure threshold and NDI; study and participant totals disagree internally. A visually symmetric funnel with few studies cannot exclude reporting bias. The stated PEDro scoring framework also needs caution.
Research review

Source-linked critical reading

Systematic review with meta-analysis of controlled clinical studies, searching four databases to October 2021 in English. Nonrandomized and allocation-unclear studies were eligible. The abstract says eight studies, whereas the flowchart, Table 1 and Discussion identify ten.

Reading depthMaterial consulted
Technical source record

Full local PDF read; All 9 PDF pages; Methods and eligibility; Table 1; Figures 1–7 and captions; Forest plots Figures 4–6 visually inspected on pages6–7; Discussion; disclosures; references

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Systematic review with meta-analysis of controlled clinical studies, searching four databases to October 2021 in English. Nonrandomized and allocation-unclear studies were eligible. The abstract says eight studies, whereas the flowchart, Table 1 and Discussion identify ten.

Participants and setting

The authors report 571 participants, 541 with neck/upper-back pain and 30 with lumbar pain. However, Table 1 and the pain forest plot sum to 570 participants (283 experimental, 287 control). These conflicting source totals must remain visible; the pooled sample is not one new cohort.

Treatment protocol

ESWT protocols varied across the included studies; Table 1 names treatments but does not provide a reproducible device, energy, pulse and session schedule for each. The review cannot define one recommended dose.

Comparison

Controls included trigger-point injection with/without TENS, dry needling, ultrasound with/without other modalities, phonophoresis and kinesiology taping. Pooling these comparators does not estimate efficacy against any single treatment. The Discussion incorrectly conflates ultrasound with ultrasound-guided pulsed radiofrequency.

What was measured

Prespecified extraction targeted end-of-treatment or one-week post-treatment VAS, pressure pain threshold and Neck Disability Index. Table 1 lists study follow-up of four to six weeks, without fully resolving the selected assessment origin. Forest plots provide the reported MDs and 95% CIs.

Results and interpretation

Reported pooled pain MD was −1.34 (95% CI −1.87 to −0.81; I²85%). Pressure threshold MD was +0.90 (0.73 to 1.07; I²98%) and NDI MD −1.79 (−2.48 to −1.10; I²92%). Figures 5 and 6 label the latter two models fixed-effect, contradicting the random-effects description. Individual comparisons with dry needling crossed the null; the review does not justify superiority to every comparator.

Harms and disclosures

No systematic pooled adverse-event outcome or event denominator is supplied. The narrative claim of no adverse effects cannot establish safety. No funding or conflicts were declared.

Limitations

High heterogeneity, nonrandomized studies, English-only inclusion and many inaccessible/excluded full texts weaken causal and coverage claims. Model labels disagree with Methods for pressure threshold and NDI; study and participant totals disagree internally. A visually symmetric funnel with few studies cannot exclude reporting bias. The stated PEDro scoring framework also needs caution.

Applicability

Evidence mostly concerns neck/upper-back MPS and short follow-up. It cannot be generalized to lumbar disease on the basis of one 30-person comparison, nor used to select a device or replace exercise.

What stronger evidence needs

Reconcile the extraction with primary reports, correct study totals and comparator labels, rerun appropriate heterogeneous-effect models and provide comparator-specific, longer-term estimates and harms.

THE ORIGINAL SOURCE

Read the original article.

Efficacy of extracorporeal shock waves in the treatment of myofascial pain syndrome: a systematic review and meta-analysis of controlled clinical studies.

Wu T, Li S, Ren J, Wang D, Ai Y. · Annals of translational medicine · 2022

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →